CHANDLER, Ariz.--(BUSINESS WIRE)--#AZBW--The Arizona Bioindustry Association (AZBio)

today announced that Clara Curiel-Lewandrowski, MD, of the University of

Arizona Cancer Center is the 2018 Arizona Bioscience Researcher of the

Year. Dr. Curiel will be honored by Arizona’s bioscience and business

communities for her leadership and her work on both the treatment and

prevention of skin cancers at the AZBio Awards on October 3, 2018, at

the Phoenix Convention Center.

Dr. Curiel is a professor and vice chair of dermatology for the

University of Arizona College of Medicine – Tucson. She holds joint

roles as the director of the Multidisciplinary Cutaneous Oncology

Program and the clinical director for the University of Arizona Cancer

Center’s Skin Cancer Institute (SCI).

Prevention and early detection are essential in the fight against skin

cancers, but when they occur, we rely on Arizona’s leading researchers

and clinicians.

The SCI unites the UA Cancer Center’s many skin cancer prevention

endeavors, bringing together innovative research, clinical care,

education and community outreach.

Since joining the UA Cancer Center in 2005, Dr. Curiel has impressed her

colleagues with her immense talent, tireless work ethic and overwhelming

motivation to fight skin cancer.

“Throughout her career, Dr. Curiel has provided exceptional and

compassionate care to patients, translated basic science into innovative

clinical applications, led groundbreaking clinical trials and invented

several technologies,” shared David Alberts, MD, founding director of

the SCI. “Dr. Curiel’s career trajectory has always been remarkable, and

we expect her to continue to reach new heights. In my more than 45 years

in academic medicine, she is one of the most brilliant investigators

with whom I have had the pleasure to work.”

Dr. Curiel’s research interests are in photobiology, early skin cancer

detection, biomarker development and primary prevention. She has taken

the initiative to address important clinical gaps in the skin cancer

prevention field through the innovative design and effective execution

of clinical studies.

“Dr. Curiel’s investigations into biomarkers for early skin cancer are

essential for finding better methods for identifying those at risk for

malignancy,” said Andrew Kraft, MD, director of the UA Cancer Center.

“She is interested in combining relevant biomarker assessment with novel

noninvasive monitoring tools, which is empowering dermatologists to

harness cutting-edge technology to better serve patients.”

Dr. Curiel has published more than 80 peer-reviewed articles and has

five patent applications. At the University of Arizona, she has trained

more than 35 graduate and postdoctoral students. She has served as the

principal investigator of 17 clinical trials, with the vast majority

being investigator-initiated studies as part of the UA NCI/DCP Cancer

Chemoprevention Consortium Agreement, P01 Skin Cancer Prevention studies

and sponsored studies.

“Dr. Curiel has a deep commitment to bring every Arizonan access to skin

cancer prevention, early detection and treatment at every stage of

disease,” said Monica Kraft, MD, chair of the Department of Medicine.

“She is a passionate clinician and investigator, and is also an engaged

community spokesperson.”

Dr. Curiel is also the sponsor for novel IND indications for approved

drugs in the skin cancer field.

“Dr. Curiel’s work is an excellent example of the value created through

the combination of scientific and clinical research,” said Joan

Koerber-Walker, president and CEO of AZBio. “Incidences of skin cancer

are on the rise. This makes the work Dr. Curiel is doing for both cancer

prevention and cancer treatment an important part of the fight against

skin cancers.”

For her commitment to pushing the frontiers of science for the

betterment of people in Arizona and around the world, Clara

Curiel-Lewandrowski, MD, is the 2018 Arizona Bioscience Researcher of

the Year.

A key component of Arizona

Bioscience Week, The AZBio Awards & Life Science Fiesta brings

together Arizona’s life science and leadership community with visitors

from around the country to celebrate life-science innovation and

innovators. The AZBio

Awards takes place on the evening of October 3, 2018, at the Phoenix

Convention Center. Highlights of the evening will include honoring

Daniel D. Von Hoff, MD, with the AZBio Pioneer Award for Lifetime

Achievement and a celebration of the achievements of leading

researchers, educators and innovator companies. The Life Science Fiesta

following the award ceremony features a Student Discovery Zone that

showcases the work of 50 students from Arizona high schools, community

colleges and universities along with exhibits featuring Arizona

companies and patient advocacy organizations. The AZBio Awards & Life

Science Fiesta is presented by AZBio and the Arizona

The White Hat Life Science Investor Conference (White

Hat 2018) brings together the next generation of biotech and health

care pioneers from across the Rocky Mountain Southwest Region with

investors locally, nationally and internationally. Held at the Phoenix

Convention Center on October 4, 2018, White Hat 2018 is a collaboration

between bioscience industry associations across the region. The

conference showcases opportunities for investment into privately held

companies in the areas of diagnostics, therapeutics, medical devices and

health information technology. Thirty-two companies have been

competitively selected by a committee of experienced life science

investors to present at White Hat 2018. Companies that presented at

White Hat in 2014 and 2016 have gone on to receive almost $200 million

in investment from private and corporate investors.

For more information on Arizona Bioscience Week, visit

For more information on the 2018 AZBio Awards, visit

For more information about White Hat 2018, visit

About Skin Cancers

  • Skin cancer is the most common form of cancer in the United States. It
    is estimated that more than 5 million new cases are diagnosed each
    year — more than all other cancers combined.

  • One in five Americans will get skin cancer in his or her lifetime with
    potential significant consequences in morbidity and mortality.

  • Detecting skin cancer before it becomes a serious problem is a team
    effort. Individuals should discuss with their primary provider their
    risk for developing skin cancer and perform skin cancer
    self-examinations at home. When patients have multiple risk factors, a
    more detailed assessment by a dermatologist might be indicated.

  • The best way to prevent skin cancer is to be sun smart, especially
    here in Arizona. This is one of the very few cancers you can prevent
    in your lifetime. When you are out in the sun, cover up, use sunscreen
    and reapply it frequently.

About AZBio

For 15 years, the Arizona Bioindustry Association (AZBio) has supported

life science innovation and life science innovators in Arizona. A key

component in Arizona’s life science ecosystem, AZBio is the only

statewide organization exclusively focused on Arizona’s bioscience

industry. AZBio membership includes patient advocacy organizations, life

science innovators, educators, health care partners and leading business

organizations. AZBio is the statewide affiliate of the Biotechnology

Innovation Organization (BIO) and works in partnership with AdvaMed,

MDMA and PhRMA to advance innovation and to ensure that the value

delivered from life-changing and life-saving innovation benefits people

in Arizona and around the world.

For more information, visit


AZBio Media Contact:

Joan Koerber-Walker, Arizona

Bioindustry Association



available upon request.